Valuation: Active Biotech AB

Market Cap 9.25Cr 91.66L 83.27L 76.94L 69.5L 1.31Cr 86Cr 1.36Cr 3.67Cr 46Cr 3.44Cr 3.37Cr 146.3Cr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 9.25Cr 91.66L 83.27L 76.94L 69.5L 1.31Cr 86Cr 1.36Cr 3.67Cr 46Cr 3.44Cr 3.37Cr 146.3Cr EV / Sales 2026 *
-
EV / Sales 2027 * 1.58x
Free-Float
83.01%
Yield 2026 *
-
Yield 2027 * -
1 day-0.85%
1 week+1.74%
Current month-12.14%
1 month+11.96%
3 months-32.37%
6 months-46.66%
Current year-23.70%
1 week 3.39
Extreme 3.39
3.69
1 month 3.1
Extreme 3.1
4.18
Current year 3.1
Extreme 3.1
9.43
1 year 3.1
Extreme 3.1
9.5
3 years 3.1
Extreme 3.1
147.8
5 years 3.1
Extreme 3.1
152
10 years 3.1
Extreme 3.1
2,190
Manager TitleAgeSince
Chief Executive Officer 64 01/07/2017
Director of Finance/CFO 75 01/01/2000
Chief Tech/Sci/R&D Officer - 01/01/2022
Director TitleAgeSince
Director/Board Member 70 07/04/2011
Chairman 61 23/05/2019
Director/Board Member 76 23/05/2019
Change 5-day change 1-year change 3-year change Capi.($)
-0.85%+1.74%-53.26%-94.37% 92.68L
-1.29%-3.91%+51.98%+69.06% 6.63TCr
-0.09%+2.79%+12.54%+95.02% 6.06TCr
+0.63%+1.64%+23.11%+89.70% 5.55TCr
-1.26%-1.45%+12.43%+117.42% 4.76TCr
-0.15%-5.06%+20.00%+29.27% 4.37TCr
-3.15%-16.63%+146.30%+685.27% 3.73TCr
+0.23%+2.14%+14.85%+46.22% 3.66TCr
+2.35%-3.61%+80.65%+60.70% 3.22TCr
+1.42%+5.84%-36.40%+402.78% 2.66TCr
Average -0.22%-0.68%+27.22%+150.11% 4TCr
Weighted average by Cap. -0.29%-1.12%+35.88%+152.75%

Financials

2026 *2027 *
Net sales - 5.86Cr 58.05L 52.74L 48.73L 44.01L 83.06L 55Cr 85.99L 2.32Cr 29Cr 2.18Cr 2.13Cr 93Cr
Net income -3.32Cr -32.89L -29.88L -27.61L -24.94L -47.06L -31Cr -48.72L -1.32Cr -17Cr -1.23Cr -1.21Cr -52Cr 2.51Cr 24.86L 22.59L 20.87L 18.85L 35.58L 23Cr 36.83L 99.45L 13Cr 93.3L 91.33L 40Cr
Net Debt - -
Projected Income Statement - Annual - Active Biotech AB
Logo Active Biotech AB
Active Biotech AB (publ) is a Sweden-based Company, which develops pharmaceutical products within medical areas where the immune defense is important, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy.
Employees
5
Date Price Change Volume
16/26/16 SEK 3.510 -0.85% 4,234
13/26/13 SEK 3.540 +0.71% 23,922
12/26/12 SEK 3.515 -2.36% 36,167
11/26/11 SEK 3.600 +4.20% 85,584
10/26/10 SEK 3.455 +0.14% 30,272
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
CCC

Net sales - Rate of surprise

Rate of surprise - Net sales - Annual - Active Biotech AB
  1. Stock Market
  2. Stocks
  3. ACTI Stock